Despite the availability of effective inhaled therapies, many patients with asthma have poor
asthma control. Uncontrolled asthma presents a significant burden on the patient and …

Inhaled corticosteroid (ICS)-containing therapies are the mainstay of pharmacological
management of asthma. They can be administered alone or in combination with a long …

Introduction Patients with asthma typically increase short-acting β 2-agonists (SABA) use
with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse …

Short-acting β2 agonists (SABAs) have been a mainstay of asthma treatment since the
1950s, and have been mainly recommended as-needed for symptom relief alongside daily …

Purpose This study was designed to assess inhaler technique skills, asthma control level,
adherence, and quality of life scores amongst asthmatic patients living in Amman, Jordan …

Asthma affects 339 million people worldwide, with an estimated 5–10% experiencing severe
asthma. In emergency settings, oral corticosteroids (OCS) can be lifesaving, but acute and …

Background Adherence to therapy has been reported worldwide as a major problem, and
that is particularly relevant on inhaled therapy for Asthma and Chronic Obstructive …

The Global Initiative of Asthma (GINA) recommends that short-acting beta 2-agonist (SABA)
monotherapy should no longer be prescribed, and that as-needed combination inhaled …

Background Many adult patients with asthma have uncontrolled disease and impaired
quality of life, despite current asthma-specific drug therapies. Objective This study aimed to …

Asthma is a complex and heterogenous disease characterized by variability in disease
expression and severity. Multiple extrapulmonary comorbidities and treatable traits are …